chr14-23995099-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_198083.4(DHRS4L2):c.374G>A(p.Ser125Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,612,748 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_198083.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DHRS4L2 | NM_198083.4 | c.374G>A | p.Ser125Asn | missense_variant | 3/8 | ENST00000335125.11 | NP_932349.2 | |
DHRS4L2 | NM_001193636.1 | c.71G>A | p.Ser24Asn | missense_variant | 3/8 | NP_001180565.1 | ||
DHRS4L2 | NM_001193637.1 | c.71G>A | p.Ser24Asn | missense_variant | 3/6 | NP_001180566.1 | ||
DHRS4L2 | NM_001193635.1 | c.222+4740G>A | intron_variant | NP_001180564.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DHRS4L2 | ENST00000335125.11 | c.374G>A | p.Ser125Asn | missense_variant | 3/8 | 1 | NM_198083.4 | ENSP00000334801.6 |
Frequencies
GnomAD3 genomes AF: 0.0000857 AC: 13AN: 151772Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251294Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135816
GnomAD4 exome AF: 0.000109 AC: 159AN: 1460976Hom.: 2 Cov.: 31 AF XY: 0.000116 AC XY: 84AN XY: 726764
GnomAD4 genome AF: 0.0000857 AC: 13AN: 151772Hom.: 0 Cov.: 32 AF XY: 0.0000675 AC XY: 5AN XY: 74070
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at